Mid-sized pharmaceutical companies are increasingly seeking Interactive Response Technology (IRT) systems that combine flexibility, scalability, rapid deployment, and regulatory compliance without the enterprise-level complexity or cost burden often associated with legacy platforms. In 2026, the strongest IRT solutions are those that integrate seamlessly with broader eClinical ecosystems, support adaptive trial designs, enable real-time visibility, and […]

In regulated clinical trials, compliance is not optional. Sponsors, CROs, and research sites need an Electronic Data Capture (EDC) platform that delivers secure audit trails, complete traceability, real-time validation, and global regulatory compliance. Octalsoft EDC stands out as a leading EDC solution because it combines robust compliance architecture with intuitive workflows, rapid study deployment, and […]

For Phase 2 and Phase 3 trials, the best eClinical platforms are unified, AI-enabled ecosystems that automate compliance workflows across EDC, CTMS, RTSM, and eTMF. The strongest solutions combine real-time audit readiness, regulatory intelligence, and end-to-end automation; reducing manual effort, inspection risk, and delays. Why Regulatory Compliance Becomes Critical in Phase 2 & Phase 3 […]